Patents by Inventor Susan A. Hudak

Susan A. Hudak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist
    Patent number: 6824781
    Abstract: Agonists or antagonists of CTACK or Vic chemokines, and various methods of use in dermatological and related applications are provided. In particular, the method makes use of fact that the CTACK or Vic chemokines are specifically capable of inducing movement of a skin cell subset. Moreover, matching of ligand with GPR2 receptor in mammals provides methods of use.
    Type: Grant
    Filed: July 2, 2001
    Date of Patent: November 30, 2004
    Assignee: Schering Corporation
    Inventors: Wei Wang, Elizabeth R. Oldham, Hortensia Soto, Ying Liu, Susan A. Hudak, Bernhard Homey, Janine M. Morales, Sirid-Aimee Kellermann, Leslie M. McEvoy, Edward P. Bowman, Albert Zlotnik
  • Lymphotactin uses
    Publication number: 20030007970
    Abstract: This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells.
    Type: Application
    Filed: May 20, 2002
    Publication date: January 9, 2003
    Applicant: Schering Corporation, a New Jersey corporation
    Inventors: Joseph A. Hedrick, Susan A. Hudak, Donna M. Rennick, Albert Zlotnik
  • Chemokine and receptor uses; compositions; methods
    Publication number: 20020160024
    Abstract: Agonists or antagonists of CTACK or Vic chemokines, and various methods of use in dermatological and related applications are provided. In particular, the method makes use of fact that the CTACK or Vic chemokines are specifically capable of inducing movement of a skin cell subset. Moreover, matching of ligand with GPR2 receptor in mammals provides methods of use.
    Type: Application
    Filed: July 2, 2001
    Publication date: October 31, 2002
    Applicant: Schering Corpration, a New Jersey corporation
    Inventors: Wei Wang, Elizabeth R. Oldham, Hortensia Soto, Ying Liu, Susan A. Hudak, Bernhard Homey, Janine M. Morales, Sirid-Aimee Kellermann, Leslie M. McEvoy, Edward P. Bowman, Albert Zlotnik
  • Lymphotactin uses
    Patent number: 6395268
    Abstract: This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells.
    Type: Grant
    Filed: December 8, 1999
    Date of Patent: May 28, 2002
    Assignee: Schering Corporation
    Inventors: Joseph A. Hedrick, Susan A. Hudak, Donna M. Rennick, Albert Zlotnik
  • Lymphotactin uses
    Patent number: 6022534
    Abstract: This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: February 8, 2000
    Assignee: Schering Corporation
    Inventors: Joseph A. Hedrick, Susan A. Hudak, Albert Zlotnik